My body was used to relying on quick, incoming fuel, and when my appetite disappeared, I did not have easy access to stored fat as a backup energy source
Tasian, G
Category-wise Analysis By Product, Ozempic Dominates the GLP-1 Receptor Agonist Market Ozempic (semaglutide) dominates with 32.1% share of the global market in 2025 , due to its strong efficacy in both glycemic control and weight management
(Article in Japanese) Sakurabayashi T, Takaesu Y, Haginoshita S, et al
Botanical insecticides, deterrents, and repellents in modern agriculture and an increasingly regulated world
48 House Armed Services Committee (HASC) Press Release, HASC Leadership Announces Bipartisan Defense Business Panel , September 12, 2011